Onderzoeker
Simon Planken
- Trefwoorden:Geneeskunde
Affiliaties
- Hematologie (Departement)
Lid
Vanaf1 okt 2023 → Heden - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf28 aug 2015 → Heden - Interne Geneeskunde (Departement)
Lid
Vanaf30 jan 2023 → 30 sep 2023 - Intensieve geneeskunde (Departement)
Lid
Vanaf1 okt 2022 → 29 jan 2023 - Interne Geneeskunde (Departement)
Lid
Vanaf1 jul 2020 → 30 sep 2021 - Hematologie (Departement)
Lid
Vanaf3 feb 2020 → 30 jun 2020 - Interne Geneeskunde (Departement)
Lid
Vanaf1 okt 2019 → 2 feb 2020 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf13 aug 2018 → 27 apr 2023
Publicaties
1 - 7 van 7
- Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer(2023)
Auteurs: Catherine Lee, Ziyue Karen Jiang, Simon Planken, Lisa K Manzuk, Roberto Ortiz, Michael Hall, Kavon Noorbehesht, Sripad Ram, Timothy Affolter, Gabriel E Troche, et al.
Pagina's: 891-900 - Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)(2021)
Auteurs: Hengmiao Cheng, Suvi T M Orr, Simon Bailey, Alexei Brooun, Ping-Jen Chen, Judith G Deal, Yali L Deng, Martin P Edwards, Gary M Gallego, Neil Grodsky, et al.
Pagina's: 644-661 - Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19(2020)
Auteurs: Robert L Hoffman, Robert S Kania, Mary A Brothers, Jay F Davies, Rose A Ferre, Ketan S Gajiwala, Mingying He, Robert J Hogan, Kirk Kozminski, Lilian Y Li, et al.
Pagina's: 12725-12747 - Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Auteurs: Teofila Seremet, Yanina Jansen, Simon Planken, Hassan Njimi, Melanie Delaunoy, Hakim El Housni, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, et al.
- Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma(2019)
Auteurs: Teofila Seremet, Simon Planken, Julia Katharina Schwarze, Yanina Jansen, Laura Vandeweerd, Robbe Van den Begin, Ioannis Tsechelidis, Danielle Lienard, Veronique Del Marmol, Bart Neyns
Pagina's: 85-88 - Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy(2018)
Auteurs: Teofila Seremet, Simon Planken, Max Schreuer, Yanina Jansen, Mélanie Delaunoy, Hakim El Housni, Danielle Lienard, Véronique Del Marmol, Pierre Heimann, Bart Neyns
Pagina's: 65-70 - Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF(V600)-mutant melanoma(2017)
Auteurs: Max Schreuer, Yanina Jansen, Simon Planken, Ines Chevolet, Teofila Seremet, Vibeke Krüse, Bart Neyns
Pagina's: 464-472